Nektar Therapeutics | NKTR - Чистый доход





Чистый доход Изменить Дата
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Amgen USD 1.33B 1.88B 2025-12
Baxter International USD -1.13B 1.08B 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cara Therapeutics USD -5.53M 621K 2025-09
Cipla INR 6.76B 6.75B 2025-12
Dr.Reddys Laboratories INR 12.1B 2.27B 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exelixis USD 193.58M 8.73M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Takeda JPY 103.64B 115.44B 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Xencor USD -6.65M 626K 2025-12